MYD88 and metabolic dysfunction-associated steatotic liver disease: The increased expression of TLR4 and MyD88 protein detected by immunoblotting (Fig. 7g) further confirmed that PNS treatment of NAFLD was associated with the LPS-induced TLR4/MyD88 signaling pathway.